BioSpace News Archive

Pharm Country

Neurogene Announces First Patient Enrolled in Natural History Study Evaluating Two Subtypes of Batten Disease

Study Enrolling Patients with CLN5 and CLN7 Subtypes Aims to Help Understand Natural Disease Course and to Help Identify Potential Clinical Endpoints for Future Gene Therapy Studies

November 12, 2020
·
4 min read
BioCapital

Emergency Physicians Urge Thanksgiving Precautions to Avoid Becoming a COVID Super Spreader Event

This Thanksgiving, the American College of Emergency Physicians recommends that holiday hosts and guests prioritize efforts to prevent the spread of COVID-19 and take steps to protect the health and safety of friends and family.

November 12, 2020
·
3 min read
Business

Motus GI Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Revenue growth reflects rebound of inpatient colonoscopy volumes in Q3 and increased demand for the Pure-Vu system from early adopter hospitals

November 12, 2020
·
8 min read
Business

Opiant Pharmaceuticals Announces Third Quarter 2020 Financial Results and Corporate Update

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, reported financial results for the three months ended September 30, 2020, and provided a corporate update.

November 12, 2020
·
11 min read
Business

C4 Therapeutics Reports Business Highlights and Third Quarter 2020 Financial Results

Strengthened leadership team with appointments of Andrew Hirsch as Chief Executive Officer, William McKee as Chief Financial Officer and Jolie M. Siegel as Chief Legal Officer

November 12, 2020
·
9 min read
Business

Steven Mickelsen, MD, Joins Acutus Medical as Chief Translational Science Officer

Acutus Medical announced the appointment of Steven Mickelsen, MD, as Chief Translational Science Officer.

November 12, 2020
·
3 min read
Business

Relay Therapeutics Reports Third Quarter 2020 Financial Results

Relay Therapeutics, Inc., a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion, reported third quarter 2020 financial results.

November 12, 2020
·
6 min read
Business

NGM Bio Provides Business Highlights and Reports Third Quarter 2020 Financial Results

NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, provided business highlights and reported financial results for the quarter ended September 30, 2020.

November 12, 2020
·
12 min read
Business

Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights

LIFT-AD clinical trial evaluating ATH-1017, a once-daily investigational drug for the treatment of mild-to-moderate Alzheimer’s disease, actively enrolling

November 12, 2020
·
8 min read
Business

aTyr Pharma Announces Third Quarter 2020 Results and Provides Corporate Update

Completesenrollment of ATYR1923clinical trial in patients with COVID-19 severe respiratory complications.Topline data is expected at turn of calendar year.

November 12, 2020
·
10 min read